GNLX Genelux Corporation - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 13, 2026
$2,56
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$2,2952-Wochen-Tief
$8,5452-Wochen-Hoch
Marktkapitalisierung (MRQ)
$115M
P/E
-3.0
EPS
$-0.86
Umsatz
$8.0K
Ihre Abzeichen
52W-Spanne
$2–$9
Analystenbewertung
BUY
Kursziel
$19
P/E
-3.0
ROE
-181.4%
Nettogewinnmarge
-401812.5%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
GNLX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.56
Marktkapitalisierung (MRQ)
$115M
P/E
-3.0
EPS
$-0.86
Umsatz
$8.0K
ROE
-181.4%
52W-Spanne
$2–$9
GNLX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$8.0K2022-12-31 → 2025-12-31
EPS$-0.862022-12-31 → 2025-12-31
Freier Cashflow$-26M2023-12-31 → 2025-12-31
Nettogewinnmarge-401812.5%2023-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | GNLX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -3.05-Jahres-Durchschnitt ≈-6.5 | ≈-6.5 | · | · | |
| P/S | 12204.5 | · | 66.2 | Überbewertet | |
| K/B (MRQ) | 7.2 | · | 2.8 | Überbewertet | |
| Kurs / FCF (TTM) | -4.0 | · | · | · | |
| Kurs / Cashflow (TTM) | -4.6 | · | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 8.55-Jahres-Durchschnitt ≈12.3 | ≈12.3 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | GNLX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Operating Margin (Betriebsgewinnmarge) | -415175.0% | · | -2097.6% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -415175.0% | · | -2097.6% | Schwach | |
| Net Profit Margin (Nettogewinnmarge) | -401812.5% | · | -1941.3% | Schwach | |
| ROA | -119.6% | · | -57.1% | Schwach | |
| ROE | -181.4% | · | -87.0% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | GNLX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 2.4 | · | 4.4 | Geringe Liquidität | |
| Quick Ratio | 0.9 | · | 3.0 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | GNLX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 0.00%5-Jahres-Durchschnitt ≈-64.6% | ≈-64.6% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -91.0% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | GNLX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.0 | · | 0.1 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$320.00 | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-5.5%
Nächster Bericht
Nov 02, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 13, 2026 | $-0.21 | $-0.20 | -4.7% |
| 31. März 2026 | Mai 13, 2026 | $-0.20 | $-0.18 | -8.9% |
| 31. Dezember 2025 | $-0.25 | $-0.22 | -12.3% | |
| 30. September 2025 | $-0.21 | $-0.22 | 2.9% | |
| 30. Juni 2025 | $-0.20 | $-0.22 | 8.8% | |
| 31. März 2025 | $-0.21 | $-0.25 | 15.1% | |
| 31. Dezember 2024 | $-0.26 | $-0.19 | -39.6% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $8.0K | $8.0K | $170.0K | $11M | |
| R&D Expense | $20M | $19M | $13M | $9M | |
| SG&A Expense | $13M | $13M | $12M | $5M | |
| Operating Expenses | $33M | $32M | $24M | $14M | |
| Operating Income | $-33M | $-32M | $-24M | $-3M | |
| Interest Income | $711.0K | $700.0K | $182.0K | · | |
| Other Non-op | $1M | $2M | $-4M | $-1M | |
| Income Tax | · | · | · | $1M | |
| Net Income | $-32M | $-30M | $-28M | $-5M | |
| EPS (Basic) | $-0.86 | $-0.95 | $-1.16 | $-0.57 | |
| EPS (Diluted) | $-0.86 | $-0.95 | $-1.16 | $-0.57 | |
| Shares (Basic) | 37,176,527 | 31,450,727 | 31,450,727 | 9,116,489 | |
| Shares (Diluted) | 37,176,527 | 31,450,727 | 24,429,278 | 9,116,489 | |
| EBITDA | $-33M | · | $-24M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $9M | $9M | $397.0K | |
| Short-term Investments | · | $22M | $14M | · | |
| Prepaid Expense | $535.0K | $653.0K | $1M | $1M | |
| Current Assets | $15M | $32M | $24M | $2M | |
| PP&E (Net) | $2M | $1M | $1M | $644.0K | |
| PP&E (Gross) | $6M | $5M | $5M | $4M | |
| Accum. Depreciation | $4M | $4M | $3M | $3M | |
| Other Non-current Assets | $144.0K | $92.0K | $92.0K | $92.0K | |
| Total Assets | $19M | $35M | $28M | $6M | |
| Accounts Payable | $4M | $6M | $4M | $7M | |
| Short-term Debt | · | · | $900.0K | · | |
| Current Liabilities | $6M | $7M | $7M | $32M | |
| Capital Leases | $1M | $2M | $2M | $1M | |
| Total Liabilities | $7M | $8M | $8M | $41M | |
| Total Debt | · | · | $900.0K | · | |
| Common Stock | $38.0K | $35.0K | $27.0K | $9.0K | |
| Paid-in Capital | $295M | $278M | $241M | $154M | |
| Retained Earnings | $-284M | $-251M | $-222M | $-190M | |
| Treasury Stock | $433.0K | $433.0K | $433.0K | $433.0K | |
| AOCI | $9.0K | $64.0K | $14.0K | $2.0K | |
| Stockholders' Equity | $12M | $26M | $19M | $-36M | |
| Liabilities + Equity | $19M | $35M | $28M | $6M | |
| Shares Outstanding | 38,139,144 | 34,728,140 | 26,788,986 | 9,126,726 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $6M | $6M | $3M | $2M | |
| Operating Cash Flow | $-25M | $-21M | $-20M | $-4M | |
| CapEx | $1M | $381.0K | $1M | $49.0K | |
| Investing Cash Flow | $12M | $-8M | $-15M | $-49.0K | |
| Stock Issued | $10M | $28M | $25M | · | |
| Net Stock Activity | $10M | · | $25M | · | |
| Financing Cash Flow | $10M | $29M | $44M | $-478.0K | |
| Net Change in Cash | $-3M | $-853.0K | $9M | $-4M | |
| Free Cash Flow | $-26M | · | $-21M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -415175.0% | · | -14214.7% | · | |
| Net Margin | -401812.5% | · | -16645.3% | · | |
| EBITDA Margin | -415175.0% | · | -14214.7% | · | |
| ROA | -119.6% | · | -169.3% | · | |
| ROE | -181.4% | · | -130.1% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 2.4 | · | 3.7 | · | |
| Quick Ratio | 0.9 | · | 3.5 | · | |
| Debt / Equity | · | · | 0.0 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $0.30 | · | $0.73 | · | |
| Revenue / Share | $0.00 | · | $0.01 | · | |
| Cash Flow / Share | $-0.68 | · | $-0.83 | · | |
| Cash / Share | $0.14 | · | $0.35 | · | |
| EPS (TTM) | $-0.86 | $-0.95 | $-1.16 | $-0.57 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 0.00% | -95.3% | -98.5% | · | |
| Revenue CAGR 3Y | -91.0% | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $8.0K | $8.0K | $170.0K | $11M | |
| Net Income TTM | $-32M | $-30M | $-28M | $-5M | |
| Market Cap | $166M | · | $375M | · | |
| Enterprise Value | · | · | $353M | · | |
| P/E | -5.1 | -2.5 | -12.1 | · | |
| P/S | 20785.8 | · | 2207.7 | · | |
| P/B | 14.4 | · | 19.3 | · | |
| P / Tangible Book | 14.4 | 3.1 | 19.3 | · | |
| P / Cash Flow | -6.6 | · | -18.5 | · | |
| P / FCF | -6.3 | · | -17.6 | · | |
| EV / EBITDA | · | · | -14.6 | · | |
| EV / FCF | · | · | -16.6 | · | |
| EV / Revenue | · | · | 2076.6 | · | |
| Earnings Yield | -19.7% | -40.2% | -8.3% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | · | · | $8.0K | · | · | $170.0K | $68.0K | $11M | |
| R&D Expense | $7M | $6M | $6M | $5M | $5M | $5M | $7M | $4M | $4M | $4M | $3M | $3M | $3M | $2M | $2M | |
| SG&A Expense | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $4M | $2M | $2M | $4M | $694.0K | $2M | |
| Operating Expenses | $10M | $9M | $9M | $8M | $8M | $8M | $10M | $7M | $7M | $8M | $5M | $5M | $7M | $3M | $5M | |
| Operating Income | $-10M | $-9M | $-9M | $-8M | $-8M | $-8M | $-10M | $-7M | $-7M | $-8M | $-5M | $-5M | $-6M | $-3M | $6M | |
| Interest Income | $127.0K | $173.0K | $128.0K | $175.0K | $224.0K | $184.0K | $201.0K | $222.0K | $163.0K | $114.0K | $4.0K | · | · | · | · | |
| Other Non-op | $174.0K | $243.0K | $165.0K | $244.0K | $336.0K | $324.0K | $772.0K | $474.0K | $316.0K | $265.0K | $-38.0K | $-426.0K | $-4M | $-401.0K | $-335.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | $6M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $1M | |
| Net Income | $-9M | $-9M | $-9M | $-8M | $-7M | $-7M | $-9M | $-6M | $-7M | $-8M | $-5M | $-6M | $-10M | $-3M | $5M | |
| EPS (Basic) | $-0.21 | $-0.20 | $-0.24 | $-0.21 | $-0.20 | $-0.21 | $-0.25 | $-0.19 | $-0.22 | $-0.29 | $-0.20 | $-0.23 | $-0.53 | $-1.00 | $0.54 | |
| EPS (Diluted) | $-0.21 | $-0.20 | $-0.24 | $-0.21 | $-0.20 | $-0.21 | $-0.25 | $-0.19 | $-0.22 | $-0.29 | $-0.20 | $-0.23 | $-0.53 | $-0.38 | $0.49 | |
| Shares (Basic) | 44,959,426 | 44,150,958 | · | 37,893,314 | 37,946,330 | 34,926,075 | · | 34,532,355 | 29,689,344 | 26,849,737 | 26,210,068 | 25,068,334 | 19,575,631 | · | 9,117,596 | |
| Shares (Diluted) | 44,959,426 | 44,150,958 | · | 37,893,314 | 37,946,330 | 34,926,075 | · | 34,532,355 | 29,689,344 | 26,849,737 | 26,210,068 | 25,068,334 | 19,575,631 | · | 10,073,788 | |
| EBITDA | $-10M | $-9M | · | $-8M | $-8M | $-8M | · | $-7M | $-7M | $-8M | $-5M | $-5M | $-6M | · | · |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $9M | $5M | · | $7M | $16M | $9M | $6M | $8M | $4M | $30M | $27M | $10M | $397.0K | · | |
| Short-term Investments | $10M | $17M | · | $16M | $21M | $19M | · | $28M | $26M | $16M | · | · | · | · | · | |
| Prepaid Expense | $474.0K | $545.0K | $535.0K | $637.0K | $1M | $843.0K | $653.0K | $2M | $1M | $2M | $1M | $2M | $2M | $1M | · | |
| Current Assets | $19M | $27M | $15M | $22M | $29M | $36M | $32M | $36M | $35M | $21M | $31M | $29M | $12M | $2M | · | |
| PP&E (Net) | $5M | $3M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $878.0K | $617.0K | $644.0K | · | |
| PP&E (Gross) | $9M | $7M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | · | |
| Accum. Depreciation | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | · | |
| Other Non-current Assets | $146.0K | $144.0K | $144.0K | $123.0K | $73.0K | $73.0K | $92.0K | $92.0K | $92.0K | $92.0K | $92.0K | $92.0K | $92.0K | $92.0K | · | |
| Total Assets | $26M | $32M | $19M | $25M | $32M | $39M | $35M | $40M | $45M | $25M | $34M | $31M | $15M | $6M | · | |
| Accounts Payable | $7M | $6M | $4M | $4M | $6M | $7M | $6M | $4M | $5M | $5M | $4M | $4M | $5M | $7M | · | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | $900.0K | $900.0K | $900.0K | · | · | |
| Current Liabilities | $8M | $7M | $6M | $5M | $7M | $8M | $7M | $6M | $6M | $8M | $9M | $8M | $11M | $32M | · | |
| Capital Leases | $2M | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | · | |
| Total Liabilities | $10M | $9M | $7M | $6M | $8M | $9M | $8M | $7M | $8M | $10M | $10M | $9M | $12M | $41M | · | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | $900.0K | $900.0K | $900.0K | · | · | |
| Common Stock | $45.0K | $45.0K | $38.0K | $38.0K | $38.0K | $38.0K | $35.0K | $35.0K | $35.0K | $27.0K | $27.0K | $26.0K | $25.0K | $9.0K | · | |
| Paid-in Capital | $318M | $316M | $295M | $293M | $291M | $289M | $278M | $276M | $274M | $245M | $239M | $232M | $207M | $154M | · | |
| Retained Earnings | $-302M | $-292M | $-284M | $-274M | $-266M | $-259M | $-251M | $-242M | $-236M | $-229M | $-215M | $-209M | $-204M | $-190M | · | |
| Treasury Stock | $433.0K | $433.0K | $433.0K | $433.0K | $433.0K | $433.0K | $433.0K | $433.0K | $433.0K | $433.0K | $433.0K | $433.0K | $433.0K | $433.0K | · | |
| AOCI | $-2.0K | $-5.0K | $9.0K | $8.0K | $3.0K | $29.0K | $64.0K | $124.0K | $-11.0K | $-5.0K | $2.0K | $2.0K | $2.0K | $2.0K | · | |
| Stockholders' Equity | $16M | $23M | $12M | $19M | $24M | $30M | $26M | $33M | $38M | $15M | $24M | $22M | $3M | $-36M | · | |
| Liabilities + Equity | $26M | $32M | $19M | $25M | $32M | $39M | $35M | $40M | $45M | $25M | $34M | $31M | $15M | $6M | · | |
| Shares Outstanding | 45,103,461 | 44,840,416 | 38,139,144 | 38,046,778 | 37,759,016 | 37,733,140 | 34,728,140 | 34,538,185 | 34,512,642 | 26,996,740 | 26,657,906 | 25,855,511 | 24,553,470 | 9,126,726 | · |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | · | $1M | $2M | $2M | $1M | $1M | $1M | $2M | $1M | $1M | $515.0K | $240.0K | $227.0K | $43.0K | $2M | |
| Operating Cash Flow | $-6M | $-6M | $-6M | $-7M | $-7M | $-5M | $-4M | $-6M | $-7M | $-4M | $-3M | $-5M | $-5M | $-2M | $-2M | |
| CapEx | $2M | $921.0K | $436.0K | $517.0K | $115.0K | $30.0K | $96.0K | $27.0K | $228.0K | $30.0K | $277.0K | $396.0K | $109.0K | $0 | $33.0K | |
| Investing Cash Flow | $6M | $-9M | $7M | $5M | $-3M | $4M | $7M | $4M | $-17M | $-2M | $-277.0K | $-396.0K | $-109.0K | $0 | $-33.0K | |
| Stock Issued | $340.0K | $19M | $0 | $0 | $0 | $10M | $15.0K | $0 | · | · | $4M | $7M | $15M | · | · | |
| Net Stock Activity | · | $19M | · | · | · | $10M | · | · | · | · | · | · | $15M | · | · | |
| Financing Cash Flow | $387.0K | $19M | $276.0K | $0 | $52.0K | $10M | $91.0K | $0 | $28M | $688.0K | $6M | $23M | $15M | $545.0K | $-329.0K | |
| Net Change in Cash | $-89.0K | $4M | $641.0K | $-2M | $-10M | $8M | $2M | $-2M | $4M | $-5M | $3M | $17M | $10M | $-973.0K | $-3M | |
| Free Cash Flow | · | $-7M | · | · | · | $-5M | · | · | · | $-4M | · | · | $-5M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | -101437.5% | · | · | -3801.2% | · | · | |
| Net Margin | · | · | · | · | · | · | · | · | · | -98125.0% | · | · | -6096.5% | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | -101437.5% | · | · | -3801.2% | · | · | |
| ROA | -32.4% | -25.0% | · | -24.4% | -19.3% | -23.5% | · | -17.4% | -17.2% | -40.0% | -31.4% | -37.1% | -141.8% | · | · | |
| ROE | -47.3% | -33.8% | · | -30.8% | -24.2% | -33.4% | · | -22.6% | -21.9% | -88.3% | -44.5% | -52.3% | -770.3% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 3.7 | · | 4.2 | 4.2 | 4.7 | · | 6.5 | 6.0 | 2.7 | 3.6 | 3.6 | 1.1 | · | · | |
| Quick Ratio | 2.3 | 3.6 | · | 3.2 | 4.0 | 4.6 | · | 6.1 | 5.8 | 2.5 | 3.4 | 3.4 | 1.0 | · | · | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.3 | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | 0.0 | · | · | 0.0 | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.36 | $0.51 | · | $0.49 | $0.63 | $0.79 | · | $0.96 | $1.09 | $0.56 | $0.90 | $0.86 | $0.11 | · | · | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | $0.00 | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.14 | · | · | · | $-0.16 | · | · | · | $-0.16 | · | · | · | · | · | |
| Cash / Share | $0.20 | $0.21 | · | · | $0.17 | $0.43 | · | $0.18 | $0.23 | $0.15 | $1.12 | $1.05 | $0.42 | · | · | |
| EPS (TTM) | $-0.86 | $-0.85 | · | $-0.87 | $-0.85 | $-0.87 | · | · | · | · | $-1.34 | $-0.65 | $-0.11 | · | · |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-36M | $-34M | · | $-32M | $-30M | $-30M | · | · | · | · | $-25M | $-15M | $-12M | · | · | |
| Market Cap | $136M | $109M | · | $160M | $108M | $102M | · | $82M | $67M | $174M | $653M | $846M | $681M | · | · | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | $624M | $820M | $672M | · | · | |
| P/E | -3.5 | -2.8 | · | -4.8 | -3.4 | -3.1 | · | · | · | · | -18.3 | -50.3 | -252.2 | · | · | |
| P/B | 8.4 | 4.7 | · | 8.6 | 4.5 | 3.4 | · | 2.5 | 1.8 | 11.5 | 27.2 | 38.0 | 253.1 | · | · | |
| P / Tangible Book | 8.4 | 4.7 | · | 8.6 | 4.5 | 3.4 | · | 2.5 | 1.8 | 11.5 | 27.2 | 38.0 | 253.1 | · | · | |
| P / Cash Flow | · | -17.9 | · | · | · | -18.7 | · | · | · | -39.9 | · | · | -148.4 | · | · | |
| Earnings Yield | -28.6% | -35.1% | · | -20.7% | -29.6% | -32.2% | · | · | · | · | -5.5% | -2.0% | -0.40% | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Umsatz | $8.0K | $8.0K | $170.0K | $11M |
| Betriebsgewinnmarge % | -415175.0% | · | -14214.7% | · |
| Nettoergebnis | $-32M | $-30M | $-28M | $-5M |
| Verwässerte EPS | $-0.86 | $-0.95 | $-1.16 | $-0.57 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Fremdkapital / Eigenkapital | · | · | 0.0 | · |
| Liquiditätsgrad | 2.4 | · | 3.7 | · |
| Quick Ratio | 0.9 | · | 3.5 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Freier Cashflow | $-26M | · | $-21M | · |
Institutionelle Eigentümer (13F) 72 Einreicher · $36.1M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
72
Gehaltener Wert
$36.1M
Neue Positionen
10
Geschlossene Positionen
11
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 10 (-4 vs. Vorquartal) | 11 (-3 vs. Vorquartal) | 20 (+5 vs. Vorquartal) | 15 (+1 vs. Vorquartal) | +473K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| WOODWARD DIVERSIFIED CAPITAL, LLC | $6.808.945 | 2.262.108 | 18,84% | Aktien |
| VANGUARD GROUP INC | $6.764.318 | 1.551.449 | 18,72% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $5.049.949 | 1.677.724 | 13,98% | Aktien |
| Bleichroeder LP | $4.155.805 | 1.380.666 | 11,50% | Aktien |
| BlackRock, Inc. | $1.323.202 | 439.602 | 3,66% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $1.322.797 | 439.213 | 3,66% | Aktien |
| CM Management, LLC | $1.204.000 | 400.000 | 3,33% | Aktien |
| BANK OF AMERICA CORP /DE/ | $989.697 | 328.803 | 2,74% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $711.395 | 236.344 | 1,97% | Aktien |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $696.529 | 231.405 | 1,93% | Aktien |
| Global Retirement Partners, LLC | $685.840 | 227.854 | 1,90% | Aktien |
| LPL Financial LLC | $475.150 | 157.857 | 1,31% | Aktien |
| STATE STREET CORP | $439.009 | 145.850 | 1,21% | Aktien |
| Provident Wealth Management, LLC | $436.173 | 144.908 | 1,21% | Aktien |
| LifeSteps Financial, Inc. | $367.115 | 121.965 | 1,02% | Aktien |
| OSAIC HOLDINGS, INC. | $367.091 | 121.958 | 1,02% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $316.739 | 105.229 | 0,88% | Aktien |
| NORTHERN TRUST CORP | $268.730 | 89.279 | 0,74% | Aktien |
| CITADEL ADVISORS LLC | $257.298 | 85.481 | 0,71% | Aktien |
| MORGAN STANLEY | $251.464 | 83.543 | 0,70% | Aktien |
| SteelPeak Wealth, LLC | $228.444 | 75.895 | 0,63% | Aktien |
| AMG National Trust Bank | $226.807 | 75.351 | 0,63% | Aktien |
| Falcon Wealth Planning | $190.187 | 63.185 | 0,53% | Aktien |
| Mariner, LLC | $159.127 | 52.866 | 0,44% | Aktien |
| Quadrature Capital Ltd | $138.102 | 45.881 | 0,38% | Aktien |
| GOLDMAN SACHS GROUP INC | $137.885 | 45.809 | 0,38% | Aktien |
| Creative Planning | $134.830 | 44.794 | 0,37% | Aktien |
| Strive Financial Group ,LLC | $124.725 | 41.437 | 0,35% | Aktien |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $124.230 | 41.000 | 0,34% | Aktien |
| Richard Young Associates, Ltd. | $123.287 | 40.959 | 0,34% | Aktien |
| XTX Topco Ltd | $119.012 | 39.539 | 0,33% | Aktien |
| UBS Group AG | $105.335 | 34.995 | 0,29% | Aktien |
| KWB Wealth | $101.706 | 23.327 | 0,28% | Aktien |
| WAYSTONE ADVISORS LLC | $100.329 | 33.332 | 0,28% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $92.581 | 30.758 | 0,26% | Aktien |
| MARSHALL WACE, LLP | $83.215 | 27.646 | 0,23% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $75.319 | 25.023 | 0,21% | Aktien |
| One Capital Management, LLC | $74.736 | 30.883 | 0,21% | Aktien |
| Point72 Asset Management, L.P. | $70.849 | 23.538 | 0,20% | Aktien |
| D.A. DAVIDSON & CO. | $65.555 | 21.779 | 0,18% | Aktien |
| Hudson Bay Capital Management LP | $64.841 | 21.542 | 0,18% | Aktien |
| 5T Wealth, LLC | $61.708 | 20.501 | 0,17% | Aktien |
| Apollon Wealth Management, LLC | $61.055 | 20.284 | 0,17% | Aktien |
| Jump Financial, LLC | $50.568 | 16.800 | 0,14% | Aktien |
| Vanguard Global Advisers, LLC | $48.190 | 16.010 | 0,13% | Aktien |
| Prime Capital Investment Advisors, LLC | $47.904 | 15.915 | 0,13% | Aktien |
| INTEGRITY ALLIANCE, LLC. | $45.307 | 15.052 | 0,13% | Aktien |
| Grange Capital, LLC | $44.322 | 14.725 | 0,12% | Aktien |
| LIBERTY WEALTH MANAGEMENT LLC | $40.044 | 16.547 | 0,11% | Aktien |
| COMMONWEALTH EQUITY SERVICES, LLC | $39.380 | 13.083 | 0,11% | Aktien |
Unternehmensinsider 19 Insider · 13 Führungskräfte · 5 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Thomas Zindrick | President and CEO | 31. August 2026 S | 1.226.427 | 0 | 6 | $-184.242 |
| Matthew Pulisic | Chief Financial Officer | 16. Juni 2026 A | 278.906 | 0 | 0 | $0 |
| Lourie S. Zak | Chief Financial Officer | 18. Dezember 2024 A | 82.452 | 0 | 0 | $0 |
| Joseph Cappello | Chief Technical Officer | 31. August 2026 S | 318.480 | 0 | 7 | $-48.390 |
| Tony Yu | Chief Scientific Officer | 31. August 2026 S | 258.688 | 0 | 6 | $-48.579 |
| Eric Groen | General Counsel | 16. Juni 2026 A | 233.957 | 0 | 0 | $0 |
| Ralph Smalling | Head of Regulatory | 3. Juni 2026 S | 67.611 | 0 | 8 | $-11.550 |
| Jason Litten | Chief Medical Officer | 2. Januar 2026 A | · | 0 | 0 | $0 |
| Sean Ryder | General Counsel | 12. Mai 2025 S | 47.621 | 0 | 0 | $0 |
| Paul Scigalla | Chief Medical Officer | 18. Oktober 2024 A | · | 0 | 0 | $0 |
| Caroline Jewett | Head of Quality | 24. Juni 2024 S | 16.174 | 0 | 0 | $0 |
| Doug Samuelson | Vice President, Finance | 11. September 2023 A | 2.303 | 0 | 0 | $0 |
| Qian Zhang | Associate VP, Research | 17. Februar 2023 A | 139.333 | 0 | 0 | $0 |
| John W Smither | Direktor | 1. Juli 2026 S | 91.403 | 0 | 1 | $-34.920 |
| John Thomas | Direktor | 16. Juni 2026 A | 501.193 | 0 | 3 | $-108.800 |
| Mary Mirabelli | Direktor | 16. Juni 2026 A | 102.693 | 0 | 0 | $0 |
| James L Tyree | Direktor | 16. Juni 2026 A | 96.483 | 0 | 0 | $0 |
| Gabe Woodward | Direktor | 17. Februar 2023 A | 4.186 | 0 | 0 | $0 |
| Aladar Szalay | 10%-Eigentümer | 13. September 2024 S | 599.821 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 3 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
GNLX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 11 Analysten
KAUF
Median-Ziel
$17.00
+564,1%
2 18,2%
Starker Kauf
8 72,7%
Kauf
1 9,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
6 Analysten · 2026-10-03Mittelwert-Ziel $18.83 +635,7%
← Unter allen Zielen
Aktueller Preis $2.56
Tief$12.00
Mittelwert$18.83
Hoch$31.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| GNLX | $166M | -5.1 | 0.00% | -401812.5% | -181.4% | · |
| HURA | · | -1.2 | · | · | · | · |
| VTVT | · | · | · | · | -70.4% | · |
| CRBP | $143M | -1.4 | · | · | -60.8% | · |
| UNCY | $128M | -3.5 | -29.0% | · | -113.9% | · |
| IMDX | $215M | -4.5 | 115.6% | -1238.5% | 330.8% | 56.7% |
| COYA | $121M | -4.6 | 123.6% | -267.1% | -59.5% | · |
| XGN | $139M | -6.5 | 19.7% | -30.0% | -103.7% | 58.3% |
| BDTX | $139M | 6.2 | · | 31.9% | 18.3% | · |
| IMUX | · | -0.9 | · | · | · | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 13, 2026